Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Dementia and Drug Discovery / Janssen Pharmaceuticals K.K.
Two of the biggest topics in modern medicine are the fight against dementia and the discovery of new drugs. Janssen in Japan is spearheading research in both areas through developing strategic partnerships. In particular, it is collaborating with other pharmaceutical companies and public organizations to further research in these two areas. One example is its recent announcement to provide the scientific community worldwide with access, free of charge, to critical data and samples from a discontinued clinical development program on Alzheimer’s disease. This initiative forms part of Janssen’s efforts to create a future where disease is a thing of the past.
This advertisement feature is produced by Nature Research Custom Media for Janssen Pharmaceutical K.K. The advertiser retains responsibility for content. About this content.
Janssen Japan is looking to Japan’s rich academic knowledge base, and investing in long-term drug development partnerships, as the face of R&D changes.